2024
Biologics for Psoriasis
Wride A, Chen G, Spaulding S, Tkachenko E, Cohen J. Biologics for Psoriasis. Dermatologic Clinics 2024, 42: 339-355. PMID: 38796266, DOI: 10.1016/j.det.2024.02.001.Peer-Reviewed Original ResearchConceptsIL-23IL-17ALong-term risk-benefit profileTNF-aLong-term adverse eventsIL-23 inhibitorsTumor necrosis factor-alphaP19 subunit of IL-23Risk-benefit profileSubunit of IL-23TNF-a inhibitorsTreatment of psoriasisNecrosis factor-alphaHigher Psoriasis AreaRates of short-termIL-12/23Psoriasis AreaIL-17FAdverse eventsIL-12IL-17Factor-alphaP19 subunitInjectable biologicsP40 subunit
2023
Association of psoriasis and systemic lupus erythematosus and mediation effects of tumor necrosis factor-α inhibitors: A cross-sectional study in the All of Us Research Program
Chen G, Hong S, Ramachandran S, Gehlhausen J, Cohen J. Association of psoriasis and systemic lupus erythematosus and mediation effects of tumor necrosis factor-α inhibitors: A cross-sectional study in the All of Us Research Program. Journal Of The American Academy Of Dermatology 2023, 90: 184-187. PMID: 37734665, DOI: 10.1016/j.jaad.2023.09.028.Peer-Reviewed Original Research
2020
Paradoxical eruptions to targeted therapies in dermatology: A systematic review and analysis
Murphy MJ, Cohen JM, Vesely MD, Damsky W. Paradoxical eruptions to targeted therapies in dermatology: A systematic review and analysis. Journal Of The American Academy Of Dermatology 2020, 86: 1080-1091. PMID: 33307146, DOI: 10.1016/j.jaad.2020.12.010.Peer-Reviewed Original ResearchMeSH KeywordsAntibodiesCytokinesDermatologyHumansInterleukin-23PsoriasisRetrospective StudiesTumor Necrosis Factor-alphaConceptsParadoxical reactionSystematic reviewNecrosis factor α inhibitorsTumor necrosis factor αSpectrum of manifestationsNecrosis factor αAntibody-based therapiesInterleukin-12/23IL-23IL-12/23Clinical featuresCutaneous reactionsEczematous eruptionInflammatory disordersProinflammatory cytokinesΑ inhibitorsRetrospective analysisIL-4RαFactor αPotential mechanismsDermatologyTherapyInhibitorsAntibodiesReaction patterns
2015
Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side Effects
Xue Y, Cohen JM, Wright NA, Merola JF. Skin Signs of Rheumatoid Arthritis and its Therapy-Induced Cutaneous Side Effects. American Journal Of Clinical Dermatology 2015, 17: 147-162. PMID: 26649439, DOI: 10.1007/s40257-015-0167-z.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, CutaneousAntirheumatic AgentsArthritis, RheumatoidBiological TherapyDermatomyositisDrug EruptionsHumansLichenoid EruptionsLupus Erythematosus, CutaneousMelanomaPyoderma GangrenosumRheumatoid NoduleRheumatoid VasculitisSkin DiseasesSkin NeoplasmsSweet SyndromeTumor Necrosis Factor-alphaConceptsRheumatoid arthritisAdverse effectsBiologic disease-modifying agentsManagement of RAAnti-TNFα agentsRA disease activityCutaneous adverse effectsSystemic inflammatory disorderCutaneous side effectsDisease-modifying agentsGranulomatous skin disorderConnective tissue disordersNeutrophilic dermatosisRheumatoid vasculitisDisease activityAggressive treatmentRheumatoid nodulesCutaneous findingsClinical presentationTherapeutic challengeGranulomatous conditionsInflammatory disordersSkin signsCutaneous diseaseCutaneous effects